Fierce Pharma

JULY 17, 2024

Bayer has claimed a second pivotal trial win for its blockbuster-to-be androgen receptor inhibitor Nubeqa, looking to reach the entire space of metastatic hormone-sensitive prostate cancer (mHSPC). | Bayer has claimed a second pivotal trial win for its blockbuster-to-be androgen receptor inhibitor Nubeqa, looking to reach the entire space of metastatic hormone-sensitive prostate cancer.

316

316

MedCity News

JULY 17, 2024

Roche reported its oral GLP-1 agonist led to an average 6.1% weight loss at four weeks, according to preliminary results from part of a Phase 1 study. The small molecule comes from Roche’s $2.7 billion acquisition of Carmot Therapeutics last year. The post Roche Weighs In With Encouraging Early Clinical Data for Oral GLP-1 Drug appeared first on MedCity News.

Biopharma 121

Biopharma Pharma 121

Fierce Pharma

JULY 17, 2024

Sanofi is looking to bulk up its workforce at its global capacity center in Hyderabad, India, with a multi-year investment totaling 400 million euros ($437 million), according to reports. | The drugmaker plans to grow it its workforce at the site to 2,600, making it the largest of Sanofi's four global capacity centers, according to reports.

298

298

PharmaTech

JULY 17, 2024

The company has issued a voluntary recall of one lot of Clonazepam Orally Disintegrating Tablets, USP (C-IV), because of incorrect strength published on product carton.

118

118

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

Fierce Pharma

JULY 17, 2024

As myriad pharma industry attempts to challenge the Inflation Reduction Act (IRA) fall flat, Johnson & Johnson is settling into a reality of pricing rebates and Medicare drug cost negotiations. | As myriad pharma industry attempts to challenge the Inflation Reduction Act (IRA) fall flat, Johnson & Johnson is settling into a reality of pricing rebates and Medicare drug cost negotiations.

Pharma 287

Pharma 287

MedCity News

JULY 17, 2024

As the prevalence of MSK conditions escalates globally, the need for effective, accessible, and equitable care solutions becomes more urgent. The post Breaking the Cycle of Chronic Pain: How Digital Care Can Address a Global Issue appeared first on MedCity News.

Physicians 115

Physicians 115

MedCity News

JULY 17, 2024

Ada Health’s CEO declined to comment on a bold PR pitch. He contends the company is profitable and at least one health system executive is satisfied with Ada’s AI symptom checker. The post PR Boasts, CEO Balks: One AI Firm’s Quest to Prove Value appeared first on MedCity News.

112

112

pharmaphorum

JULY 17, 2024

Roche has reported early-stage clinical data with an oral GLP-1 agonist acquired as part of its $3.

111

111

MedCity News

JULY 17, 2024

It’s time to hold ourselves to a higher standard. Our industry needs to reimagine what can be accomplished in member engagement by more effectively incorporating behavioral science principles and personalization into our solutions, just as leaders in other industries have done. The post Traditional Member Engagement is Broken. Daily Care Motivation is the Only Way to Improve Outcomes appeared first on MedCity News.

Patients 105

Patients 105

pharmaphorum

JULY 17, 2024

Huma raised $80m to support a cloud platform that can be used by digital health developers to create disease management tools

Management 105

Management 105

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

MedCity News

JULY 17, 2024

As poor experiences and high costs drive many to walk away from their doctors, the right additional support can keep patients from switching providers. Here are three suggestions to consider that could make a difference for patient experience while improving access to care and reducing costs. The post Three Remote Nursing Strategies to Fight Patient Burnout appeared first on MedCity News.

Patients 105

Patients Doctors 105

pharmaphorum

JULY 17, 2024

Vertex Pharma has teamed up with Orum Therapeutics to develop a conditioning regimen, used to prepare patients to receive gene-editing medicines, that it hopes will offer a more tolerable alternative to current chemotherapy options.Vertex is paying $15 million upfront to get the ball rolling on the collaboration, which could be worth up to $945 million if it exercises options to use the technology for three developmental programmes and all of them hit various milestones.

Medicine 104

Medicine Pharma Patients 104

MedCity News

JULY 17, 2024

Thyme Care’s Series C funding round includes investments from Concord Health Partners, CVS Health Ventures, Town Hall Ventures, a16z Bio + Health, AlleyCorp, Echo Health Ventures, Frist Cressey Ventures and Foresite Capital. The post Thyme Care Raises $95M To Advance Cancer Care appeared first on MedCity News.

105

105

PharmaTimes

JULY 17, 2024

The most globally prevalent cancers include breast, lung, bowel and prostate cancers

101

101

Advertisement

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

Sales

European Pharmaceutical Review

JULY 17, 2024

European Pharmacopoeia has confirmed it will remove the rabbit pyrogen test (RPT) from its monographs. This milestone decision was made during the Ph. Eur.’s 179th session in June 2024. The RPT has been the traditional detection method for pyrogens, the European Directorate for the Quality Of Medicines (EDQM) explained. In June 2021, the European Pharmacopoeia Commission (EPC) committed to completely replace the RPT in the 59 Ph.

Medicine 98

Medicine Pharmaceutical 98

Copyright Clearance Center

JULY 17, 2024

Copyright Clearance Center's AI re-use rights offer stands in its Annual Copyright Licenses subscription program for 'millions of works.

98

98

Pharmaceutical Technology

JULY 17, 2024

In January, the US House Select Committee on the Strategic Competition between the US and the Chinese Communist Party introduced the Biosecure Act.

Pharmaceutical 98

Pharmaceutical Competition Marketing 98

pharmaphorum

JULY 17, 2024

The hot list of policies for the new Labour government in the UK, laid out in the King's Speech today, focused mainly on economic growth but included several announcements related to health.Along with a general commitment to improving the NHS as "a service for all," it highlighted a commitment to reduce waiting times – still close to record levels – as well as a focus on prevention and mental health services, particularly for young people.

Government 85

Government 85

Advertisement

PharmaTimes

JULY 17, 2024

The new technology can generate a target infection within 30 minutes to two hours

73

73

pharmaphorum

JULY 17, 2024

Bayer has the result it was hoping for in the phase 3 ARANOTE trial of Nubeqa in metastatic, hormone-sensitive prostate cancer (mHSPC), a key part of its plan to build the drug into a €3 billion-a-year blockbuster.ARANOTE compared Nubeqa (darolutamide) to placebo given with standard androgen deprivation therapy (ADT) and showed a significant improvement with Bayer's oral androgen receptor inhibitor (ARi) on radiological progression-free survival (rPFS), without adding significantly to the side e

Side effects 80

Side effects 80

Pharmaceutical Technology

JULY 17, 2024

The US FDA has issued a complete response letter (CRL) to Orexo regarding its NDA for OX124 to counteract opioid overdoses.

FDA 66

FDA Medical 66

Clarivate

JULY 17, 2024

The Clarivate Top 100 Global Innovators report is a beacon of insight into global innovation across various sectors and industries. In a new series of deep dive analyses, we delve into specific trends within four industry segments, starting with the dynamic energy and electrical segment. Energy production, consumption, and distribution are pivotal macro trends that intersect with sustainability, climate action and economic prosperity.

Leads 59

Leads Electronics Distribution Engineering 59

Advertisement

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

Sales

Pharmaceutical Technology

JULY 17, 2024

Upperton Pharma has received the UK Medicines and Healthcare products Regulatory Agency (MHRA) approval for its facility in Nottingham.

Manufacturing 59

Manufacturing Medicine Pharma Healthcare 59

Pharmacy Times

JULY 17, 2024

Radiotherapy may have applications beyond symptomatic relief when used in combination with immunotherapy.

Patients 52

Patients 52

Pharmaceutical Technology

JULY 17, 2024

As US China trade relations are set to be impacted by the BIOSECURE Act, pharma companies exploring CDMOs outside China may need to contend with increased drug development and manufacturing costs.

Manufacturing 59

Manufacturing Pharma 59

Pharmacy Times

JULY 17, 2024

Currently, limited data show the effect of adverse drug events in the outpatient setting.

52

52

Advertisement

Distribution

Scott’s Directories

JULY 17, 2024

The healthcare landscape is rapidly evolving, and pharmaceutical marketing needs to adapt to keep pace. One of the most powerful tools at your disposal is prescription data. Understanding how to leverage this data can significantly enhance your marketing strategies, ensuring that your efforts are targeted, efficient, and successful. This article will explore how to maximize prescription data for effective pharmaceutical marketing.

Prescription 52

Prescription Marketing Pharmaceutical Doctors 52

PharmExec

JULY 17, 2024

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

Manufacturing 52

Manufacturing 52

Contrarian Sales Techniques

JULY 17, 2024

Why Personal Growth is Your Secret Weapon Ok, hear me out. Before you roll your eyes, let's talk about why focusing on yourself is actually the best thing you can do for your sales career. It's not selfish; it's smart. See, sales isn't just about closing deals. It's about building relationships, understanding people, and being the best version of yourself.

Sales 52

Sales Media Leads Sales Strategy 52

Evolve Your Success

JULY 17, 2024

Sam Cooper, the senior district Sales Manager for InMode, joins us to share his remarkable journey from copier sales to becoming a leading figure in the aesthetic medical sales industry. Hear about his engaging experiences with celebrity plastic surgeons in Los Angeles and his insights into the Medical Sales Career Builder program, which aims to help candidates stand out in this highly competitive field.

Medical sales 52

Medical sales Sales Education Medical 52

Advertisement

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A

Sales